Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney

被引:104
作者
Kim, Hyun Ju [1 ]
Moradi, Hamid [1 ]
Yuan, Jun [1 ]
Norris, Keith [2 ]
Vaziri, Nosratola D. [1 ]
机构
[1] Univ Calif Irvine, Div Nephrol & Hypertens, Irvine, CA 92717 USA
[2] Charles R Drew Univ Med & Sci, Los Angeles, CA 90059 USA
关键词
chronic kidney disease; lipid metabolism; nuclear transcription factors\sterol regulatory element binding proteins; scavenger receptors; CD36; LXR; ABCA-1; transporter; fatty acid synthase; PPAR alpha; PROLIFERATOR-ACTIVATED RECEPTOR; ELEMENT-BINDING PROTEINS; LIVER-X-RECEPTOR; DENSITY-LIPOPROTEIN RECEPTOR-1; BOUND TRANSCRIPTION FACTOR; ARTERY ENDOTHELIAL-CELLS; OX-LDL RECEPTOR-1; NF-KAPPA-B; CARDIOVASCULAR-DISEASE; CHOLESTEROL-METABOLISM;
D O I
10.1152/ajprenal.90761.2008
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Kim HJ, Moradi H, Yuan J, Norris K, Vaziri ND. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol 296: F1297-F1306, 2009. First published April 8, 2009; doi: 10.1152/ajprenal.90761.2008.-A significant reduction of renal mass results in proteinuria, glomerulosclerosis, and tubulointerstitial injury, culminating in end-stage chronic renal failure (CRF). The accumulation of lipids in the kidney can cause renal disease. Uptake of oxidized lipoproteins via scavenger receptors, reabsorption of filtered protein-bound lipids via the megalin-cubilin complex, and increased glucose load per nephron can promote lipid accumulation in glomerular, tubular, and interstitial cells in CRF. Cellular lipid homeostasis is regulated by lipid influx, synthesis, catabolism, and efflux. We examined lipid-regulatory factors in the remnant kidney of rats 11 wk after 5/6 nephrectomy (CRF) or sham operation. CRF resulted in azotemia, proteinuria, lipid accumulation in the kidney, upregulation of megalin, cubilin, mediators of lipid influx (scavenger receptor class A and lectin-like oxidized receptor-1), lipid efflux (liver X receptor alpha/beta and ATP-binding cassette transporter), and fatty acid biosynthesis (carbohydrate-response element binding protein, fatty acid synthase, and acetyl-CoA carboxylase). However, factors involved in cholesterol biosynthesis (sterol regulatory element binding protein, 3-hydroxy-3-methylglutaryl coenzyme A reductase, SCAP, Insig-1, and Insig-2) and fatty acid oxidation (peroxisome proliferator-activated receptor, acyl-CoA oxidase, and liver-type fatty acid binding protein) were reduced in the remnant kidney. Thus CRF results in heavy lipid accumulation in the remnant kidney, which is mediated by upregulation of pathways involved in tubular reabsorption of filtered protein-bound lipids, influx of oxidized lipoproteins and synthesis of fatty acids, and downregulation of pathways involved in fatty acid catabolism.
引用
收藏
页码:F1297 / F1306
页数:10
相关论文
共 59 条
[1]   Cellular lipid metabolism and the role of lipids in progressive renal disease [J].
Abrass, CK .
AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (01) :46-53
[2]   The Molecular Interactions between Filtered Proteins and Proximal Tubular Cells in Proteinuria [J].
Baines, Richard J. ;
Brunskill, Nigel J. .
NEPHRON EXPERIMENTAL NEPHROLOGY, 2008, 110 (02) :E67-E71
[3]   Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis [J].
Barbier, O ;
Torra, IP ;
Duguay, Y ;
Blanquart, C ;
Fruchart, JC ;
Glineur, C ;
Staels, B .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) :717-726
[4]   SREBP in signal transduction: cholesterol metabolism and beyond [J].
Bengoechea-Alonso, Maria T. ;
Ericsson, Johan .
CURRENT OPINION IN CELL BIOLOGY, 2007, 19 (02) :215-222
[5]   The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits [J].
Bocan, TMA ;
Krause, BR ;
Rosebury, WS ;
Mueller, SB ;
Lu, XK ;
Dagle, C ;
Major, T ;
Lathia, C ;
Lee, H .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (01) :70-79
[6]   Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years [J].
Bosmans, JL ;
Holvoet, P ;
Dauwe, SEH ;
Ysebaert, DK ;
Chapelle, T ;
Jürgens, A ;
Kovacic, V ;
Van Marck, EA ;
De Broe, ME ;
Verpooten, GA .
KIDNEY INTERNATIONAL, 2001, 59 (06) :2346-2356
[7]   The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor [J].
Brown, MS ;
Goldstein, JL .
CELL, 1997, 89 (03) :331-340
[8]   A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood [J].
Brown, MS ;
Goldstein, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11041-11048
[9]   LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis [J].
Chen, MJ ;
Masaki, T ;
Sawamura, T .
PHARMACOLOGY & THERAPEUTICS, 2002, 95 (01) :89-100
[10]   The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide [J].
Cominacini, L ;
Rigoni, A ;
Fratta Pasini, A ;
Garbin, U ;
Davoli, A ;
Campagnola, R ;
Pastorino, AM ;
Lo Cascio, V ;
Sawamura, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) :13750-13755